Page last updated: 2024-08-23

pipecuronium and Neuromuscular Junction Diseases

pipecuronium has been researched along with Neuromuscular Junction Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asztalos, L; Fülesdi, B; Lengyel, S; Nemes, R; Pongrácz, A; Tassonyi, E	1

Trials

1 trial(s) available for pipecuronium and Neuromuscular Junction Diseases

Article	Year
Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial. Anesthesia and analgesia, 2015, Volume: 121, Issue:2 Topics: Adult; Aged; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Inhalation; Antidotes; Double-Blind Method; Female; gamma-Cyclodextrins; Humans; Hungary; Male; Methyl Ethers; Middle Aged; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Junction; Neuromuscular Junction Diseases; Neuromuscular Monitoring; Pipecuronium; Recovery of Function; Sevoflurane; Sugammadex; Time Factors; Treatment Outcome	2015

Article

Year

Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.

Anesthesia and analgesia, 2015, Volume: 121, Issue:2

Topics: Adult; Aged; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Inhalation; Antidotes; Double-Blind Method; Female; gamma-Cyclodextrins; Humans; Hungary; Male; Methyl Ethers; Middle Aged; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Junction; Neuromuscular Junction Diseases; Neuromuscular Monitoring; Pipecuronium; Recovery of Function; Sevoflurane; Sugammadex; Time Factors; Treatment Outcome

2015